Cargando…

Identification of large variation in pfcrt, pfmdr-1 and pfubp-1 markers in Plasmodium falciparum isolates from Ethiopia and Tanzania

BACKGROUND: Plasmodium falciparum resistance to anti-malarials is a major drawback in effective malaria control and elimination globally. Artemisinin-combination therapy (ACT) is currently the key first-line treatment for uncomplicated falciparum malaria. Plasmodium falciparum genetic signatures at...

Descripción completa

Detalles Bibliográficos
Autores principales: Golassa, Lemu, Kamugisha, Erasmus, Ishengoma, Deus S, Baraka, Vito, Shayo, Alex, Baliraine, Frederick N, Enweji, Nizar, Erko, Berhanu, Aseffa, Abraham, Choy, Angel, Swedberg, Göte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4495614/
https://www.ncbi.nlm.nih.gov/pubmed/26152336
http://dx.doi.org/10.1186/s12936-015-0783-3
_version_ 1782380279754653696
author Golassa, Lemu
Kamugisha, Erasmus
Ishengoma, Deus S
Baraka, Vito
Shayo, Alex
Baliraine, Frederick N
Enweji, Nizar
Erko, Berhanu
Aseffa, Abraham
Choy, Angel
Swedberg, Göte
author_facet Golassa, Lemu
Kamugisha, Erasmus
Ishengoma, Deus S
Baraka, Vito
Shayo, Alex
Baliraine, Frederick N
Enweji, Nizar
Erko, Berhanu
Aseffa, Abraham
Choy, Angel
Swedberg, Göte
author_sort Golassa, Lemu
collection PubMed
description BACKGROUND: Plasmodium falciparum resistance to anti-malarials is a major drawback in effective malaria control and elimination globally. Artemisinin-combination therapy (ACT) is currently the key first-line treatment for uncomplicated falciparum malaria. Plasmodium falciparum genetic signatures at pfmdr-1, pfcrt, and pfubp-1 loci are known to modulate in vivo and in vitro parasite response to ACT. The objective of this study was to assess the distribution of these resistance gene markers in isolates collected from different malaria transmission intensity in Ethiopia and Tanzania. METHODS: Plasmodium falciparum clinical isolates were collected from different regions of Ethiopia and Tanzania. Genetic polymorphisms in the genes pfcrt, pfmdr-1 and pfubp-1 were analysed by PCR and sequencing. Frequencies of the different alleles in the three genes were compared within and between regions, and between the two countries. RESULTS: The majority of the isolates from Ethiopia were mutant for the pfcrt 76 and wild-type for pfmdr-1 86. In contrast, the majority of the Tanzanian samples were wild-type for both pfcrt and pfmdr-1 loci. Analysis of a variable linker region in pfmdr-1 showed substantial variation in isolates from Tanzania as compared to Ethiopian isolates that had minimal variation. Direct sequencing of the pfubp-1 region showed that 92.8% (26/28) of the Ethiopian isolates had identical genome sequence with the wild type reference P. falciparum strain 3D7. Of 42 isolates from Tanzania, only 13 (30.9%) had identical genome sequences with 3D7. In the Tanzanian samples, 10 variant haplotypes were identified. CONCLUSION: The majority of Ethiopian isolates carried the main marker for chloroquine (CQ) resistance, while the majority of the samples from Tanzania carried markers for CQ susceptibility. Polymorphic genes showed substantially more variation in Tanzanian isolates. The low variability in the polymorphic region of pfmdr-1 in Ethiopia may be a consequence of low transmission intensity as compared to high transmission intensity and large variations in Tanzania.
format Online
Article
Text
id pubmed-4495614
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44956142015-07-09 Identification of large variation in pfcrt, pfmdr-1 and pfubp-1 markers in Plasmodium falciparum isolates from Ethiopia and Tanzania Golassa, Lemu Kamugisha, Erasmus Ishengoma, Deus S Baraka, Vito Shayo, Alex Baliraine, Frederick N Enweji, Nizar Erko, Berhanu Aseffa, Abraham Choy, Angel Swedberg, Göte Malar J Research BACKGROUND: Plasmodium falciparum resistance to anti-malarials is a major drawback in effective malaria control and elimination globally. Artemisinin-combination therapy (ACT) is currently the key first-line treatment for uncomplicated falciparum malaria. Plasmodium falciparum genetic signatures at pfmdr-1, pfcrt, and pfubp-1 loci are known to modulate in vivo and in vitro parasite response to ACT. The objective of this study was to assess the distribution of these resistance gene markers in isolates collected from different malaria transmission intensity in Ethiopia and Tanzania. METHODS: Plasmodium falciparum clinical isolates were collected from different regions of Ethiopia and Tanzania. Genetic polymorphisms in the genes pfcrt, pfmdr-1 and pfubp-1 were analysed by PCR and sequencing. Frequencies of the different alleles in the three genes were compared within and between regions, and between the two countries. RESULTS: The majority of the isolates from Ethiopia were mutant for the pfcrt 76 and wild-type for pfmdr-1 86. In contrast, the majority of the Tanzanian samples were wild-type for both pfcrt and pfmdr-1 loci. Analysis of a variable linker region in pfmdr-1 showed substantial variation in isolates from Tanzania as compared to Ethiopian isolates that had minimal variation. Direct sequencing of the pfubp-1 region showed that 92.8% (26/28) of the Ethiopian isolates had identical genome sequence with the wild type reference P. falciparum strain 3D7. Of 42 isolates from Tanzania, only 13 (30.9%) had identical genome sequences with 3D7. In the Tanzanian samples, 10 variant haplotypes were identified. CONCLUSION: The majority of Ethiopian isolates carried the main marker for chloroquine (CQ) resistance, while the majority of the samples from Tanzania carried markers for CQ susceptibility. Polymorphic genes showed substantially more variation in Tanzanian isolates. The low variability in the polymorphic region of pfmdr-1 in Ethiopia may be a consequence of low transmission intensity as compared to high transmission intensity and large variations in Tanzania. BioMed Central 2015-07-08 /pmc/articles/PMC4495614/ /pubmed/26152336 http://dx.doi.org/10.1186/s12936-015-0783-3 Text en © Golassa et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Golassa, Lemu
Kamugisha, Erasmus
Ishengoma, Deus S
Baraka, Vito
Shayo, Alex
Baliraine, Frederick N
Enweji, Nizar
Erko, Berhanu
Aseffa, Abraham
Choy, Angel
Swedberg, Göte
Identification of large variation in pfcrt, pfmdr-1 and pfubp-1 markers in Plasmodium falciparum isolates from Ethiopia and Tanzania
title Identification of large variation in pfcrt, pfmdr-1 and pfubp-1 markers in Plasmodium falciparum isolates from Ethiopia and Tanzania
title_full Identification of large variation in pfcrt, pfmdr-1 and pfubp-1 markers in Plasmodium falciparum isolates from Ethiopia and Tanzania
title_fullStr Identification of large variation in pfcrt, pfmdr-1 and pfubp-1 markers in Plasmodium falciparum isolates from Ethiopia and Tanzania
title_full_unstemmed Identification of large variation in pfcrt, pfmdr-1 and pfubp-1 markers in Plasmodium falciparum isolates from Ethiopia and Tanzania
title_short Identification of large variation in pfcrt, pfmdr-1 and pfubp-1 markers in Plasmodium falciparum isolates from Ethiopia and Tanzania
title_sort identification of large variation in pfcrt, pfmdr-1 and pfubp-1 markers in plasmodium falciparum isolates from ethiopia and tanzania
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4495614/
https://www.ncbi.nlm.nih.gov/pubmed/26152336
http://dx.doi.org/10.1186/s12936-015-0783-3
work_keys_str_mv AT golassalemu identificationoflargevariationinpfcrtpfmdr1andpfubp1markersinplasmodiumfalciparumisolatesfromethiopiaandtanzania
AT kamugishaerasmus identificationoflargevariationinpfcrtpfmdr1andpfubp1markersinplasmodiumfalciparumisolatesfromethiopiaandtanzania
AT ishengomadeuss identificationoflargevariationinpfcrtpfmdr1andpfubp1markersinplasmodiumfalciparumisolatesfromethiopiaandtanzania
AT barakavito identificationoflargevariationinpfcrtpfmdr1andpfubp1markersinplasmodiumfalciparumisolatesfromethiopiaandtanzania
AT shayoalex identificationoflargevariationinpfcrtpfmdr1andpfubp1markersinplasmodiumfalciparumisolatesfromethiopiaandtanzania
AT balirainefrederickn identificationoflargevariationinpfcrtpfmdr1andpfubp1markersinplasmodiumfalciparumisolatesfromethiopiaandtanzania
AT enwejinizar identificationoflargevariationinpfcrtpfmdr1andpfubp1markersinplasmodiumfalciparumisolatesfromethiopiaandtanzania
AT erkoberhanu identificationoflargevariationinpfcrtpfmdr1andpfubp1markersinplasmodiumfalciparumisolatesfromethiopiaandtanzania
AT aseffaabraham identificationoflargevariationinpfcrtpfmdr1andpfubp1markersinplasmodiumfalciparumisolatesfromethiopiaandtanzania
AT choyangel identificationoflargevariationinpfcrtpfmdr1andpfubp1markersinplasmodiumfalciparumisolatesfromethiopiaandtanzania
AT swedberggote identificationoflargevariationinpfcrtpfmdr1andpfubp1markersinplasmodiumfalciparumisolatesfromethiopiaandtanzania